Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, A. Jacob, Eric C. Klawiter et al.|Research Padua Archive (University of Padua)|2020Cited by 139
Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitisΑναστασία Ζεκερίδου, Jérôme Honnorat, Jean‐Christophe Antoine et al.|Journal of Neurology|2015Cited by 120
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Ludwig Kappos, Stephen L. Hauser et al.|Multiple Sclerosis Journal|2022Cited by 103
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseasesChé Serguera, Kumaran Deiva|Journal of Neuroinflammation|2019Cited by 20